| Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition AJ Greaney, TN Starr, P Gilchuk, SJ Zost, E Binshtein, AN Loes, SK Hilton, ... Cell host & microbe 29 (1), 44-57. e9, 2021 | 1148 | 2021 |
| TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes R Zang, MFG Castro, BT McCune, Q Zeng, PW Rothlauf, NM Sonnek, ... Science immunology 5 (47), eabc3582, 2020 | 1048 | 2020 |
| N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 M McCallum, A De Marco, F Lempp, MA Tortorici, D Pinto, AC Walls, ... Cell, 2021 | 934 | 2021 |
| Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization Z Liu*, LA VanBlargan*, LM Bloyet, PW Rothlauf, RE Chen, S Stumpf, ... Cell host & microbe 29 (3), 477-488. e4, 2021 | 758 | 2021 |
| SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape TN Starr*, N Czudnochowski*, Z Liu*, F Zatta, YJ Park, A Addetia, D Pinto, ... Nature 597 (7874), 97-102, 2021 | 459 | 2021 |
| Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2 JB Case, PW Rothlauf, RE Chen, Z Liu, H Zhao, AS Kim, LM Bloyet, ... Cell host & microbe 28 (3), 475-485. e5, 2020 | 415 | 2020 |
| Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study P Deepak, W Kim, MA Paley, M Yang, AB Carvidi, EG Demissie, ... Annals of internal medicine 174 (11), 1572-1585, 2021 | 308 | 2021 |
| Germinal centre-driven maturation of B cell response to mRNA vaccination W Kim, JQ Zhou, SC Horvath, AJ Schmitz, AJ Sturtz, T Lei, Z Liu, ... Nature 604 (7904), 141-145, 2022 | 278 | 2022 |
| Broad sarbecovirus neutralization by a human monoclonal antibody MA Tortorici, N Czudnochowski, TN Starr, R Marzi, AC Walls, F Zatta, ... Nature 597 (7874), 103-108, 2021 | 237 | 2021 |
| In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains RE Chen, ES Winkler, JB Case, ID Aziati, TL Bricker, A Joshi, TL Darling, ... Nature 596 (7870), 103-108, 2021 | 235 | 2021 |
| Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion R Zang, JB Case, E Yutuc, X Ma, S Shen, MF Gomez Castro, Z Liu, ... Proceedings of the National Academy of Sciences 117 (50), 32105-32113, 2020 | 226 | 2020 |
| Imprinted antibody responses against SARS-CoV-2 Omicron sublineages YJ Park*, D Pinto*, AC Walls*, Z Liu*, A De Marco, F Benigni, F Zatta, ... Science 378 (6620), 619-627, 2022 | 204 | 2022 |
| Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2 YL Kang, Y Chou, PW Rothlauf, Z Liu, TK Soh, D Cureton, JB Case, ... Proceedings of the National Academy of Sciences 117 (34), 20803-20813, 2020 | 194 | 2020 |
| Defining the risk of SARS-CoV-2 variants on immune protection MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ... Nature 605 (7911), 640-652, 2022 | 161 | 2022 |
| Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell M Puray-Chavez, KM LaPak, TP Schrank, JL Elliott, DP Bhatt, ... Cell Reports 36 (2), 2021 | 142 | 2021 |
| Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry YJ Park*, A De Marco*, TN Starr*, Z Liu*, D Pinto, AC Walls, F Zatta, ... Science 375 (6579), 449-454, 2022 | 135 | 2022 |
| SARS-CoV-2 Omicron boosting induces de novo B cell response in humans WB Alsoussi, SK Malladi, JQ Zhou, Z Liu, B Ying, W Kim, AJ Schmitz, T Lei, ... Nature 617 (7961), 592-598, 2023 | 117 | 2023 |
| Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells L Tao, S Tian, J Zhang, Z Liu, L Robinson-McCarthy, SI Miyashita, ... Nature microbiology 4 (10), 1760-1769, 2019 | 103 | 2019 |
| Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice DB Andrew C. Hunt, James Brett Case, Young-Jun Park, Longxing Cao, Kejia Wu ... Science Translational Medicine, 2022 | 100 | 2022 |
| A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope LA VanBlargan*, LJ Adams*, Z Liu*, RE Chen, P Gilchuk, S Raju, ... Immunity 54 (10), 2399-2416. e6, 2021 | 99 | 2021 |
Michael S. DiamondProfessor, Washington UniversityVerified email at wusm.wustl.edu